Tech Company Financing Transactions
DuraStat Funding Round
On 4/29/2022, DuraStat raised $5 million in Series B funding from private investors.
Transaction Overview
Company Name
Announced On
4/29/2022
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to proliferate its flagship dural repair product to every spine facility and to accelerate upcoming product launches.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1101 E. 6th St, Unit B
Austin, TX 78702
USA
Austin, TX 78702
USA
Phone
Website
Email Address
Overview
DuraStat is a surgical device that enables higher-quality, gold standard dural repairs with efficiency, even when access is limited. The needle and suture, retained within the smooth, curved tip enable pre-selection of optimal location for needle placement and suture passage.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Alex Lukianov
Chief Executive Officer
Adam Azzara
Co-Founder
Greg Anderson
Co-Founder
Mark Kurd
Founder
Kevin Foley
Browse more venture capital transactions:
Prev: 4/28/2022: Deepset venture capital transaction
Next: 4/29/2022: VisionNav venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs